J. Schellens

Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.

Marc Maliepaard, M A van Gastelen, L A de Jong et al. · PubMed · 1999 · 487 citations

Chemoprevention Strategy, Pathology, Cancer Biology +18

Role of Body Surface Area in Dosing of Investigational Anticancer Agents in Adults, 1991-2001

Sharyn D. Baker, Jaap Verweij, Eric K. Rowinsky et al. · JNCI Journal of the National Cancer Institute · 2002 · 285 citations · Full text

Drug Safety, Investigational Anticancer Agents, Therapeutic Drug Monitoring +13

Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.

Melanie Mackean, André Planting, Chris Twelves et al. · Journal of Clinical Oncology · 1998 · 266 citations

Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.

G L Scheffer, Marc Maliepaard, A C Pijnenborg et al. · PubMed · 2000 · 170 citations

Breast Oncology, Immunology, Pathology +17

Transport of Topoisomerase I Inhibitors by the Breast Cancer Resistance Protein: Potential Clinical Implications

J. Schellens, Marc Maliepaard, Rik J. Scheper et al. · Annals of the New York Academy of Sciences · 2000 · 112 citations